Compliance with good manufacturing practice (“GMP”) is mandatory for all medicinal products that have been granted a marketing authorisation. Likewise, the manufacture of investigational medicinal products must be in accordance with GMP. Advanced therapy medicinal products that are administered to patients under Article 3 of Directive 2001/83/EC (so called “hospital exemption”) must be manufactured under equivalent quality standards to the manufacturing of advanced therapy medicinal products with a marketing authorisation.
Article 5 of Regulation (EC) No 1394/2007 mandates the Commission to draw up guidelines on good manufacturing practice specific to advanced therapy medicinal products ("ATMPs"). Article 63(1) of Regulation (EU) No 536/2014 also empowers the Commission to adopt and publish detailed guidelines on good manufacturing practice applicable to investigational medicinal products.
EC 22.11.2017
EudraLex 22.11.2017
| Descrizione | Lingua | Dimensioni | Downloads | |
|---|---|---|---|---|
 |
IT | 965 kB | 915 |
della Commissione del 14 dicembre 2018 relativa all'identificazione dell'1,7,7-trimetil-3(fenilmetilene)biciclo[2.2.1]eptan-2-one (3-benzilidene canfora) come sos...
Regolamento (UE) n. 453/2010 della Commissione del 20 maggio 2010 recante modifica del regolamento (CE) n. 1907/2006 del Parlamento europeo e del Consiglio concernente la ...
Corte dei Conti Europea, 15/01/2019
La sicurezza alimentare costituisce una priorità importante per l’UE e riguarda tutti i ...
Testata editoriale iscritta al n. 22/2024 del registro periodici della cancelleria del Tribunale di Perugia in data 19.11.2024